ALS News Today Home | ALS News Today
4 days ago · Qalsody (tofersen) halted disease progression and improved functional independence and mobility in people with amyotrophic lateral sclerosis (ALS) who received the treatment in a real-world setting, according to a study involving seven patients carrying mutations in the SOD1 gene.
Amyotrophic Lateral Sclerosis News -- ScienceDaily
Mar 13, 2024 · Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments.
News - The ALS Association
ALS Association's Top Priorities Transformed into New Laws for Hoosiers Living with ALS. Stay up to date with the latest ALS news, with stories centered around research, care services, and advocacy.
New Treatment Strategy Offers Hope for Halting ALS Progression
Jan 30, 2024 · A major breakthrough in the treatment of amyotrophic lateral sclerosis, known as ALS, can potentially help stop the disease in its tracks in as much as half of the cases in the U.S., a Northeastern University scientist says.
National Academies Releases Road Map for Turning ALS from …
June 18, 2024 (Arlington, VA) – The ALS Association commends the National Academies for its groundbreaking new report on amyotrophic lateral sclerosis (ALS). The report, the result of an 18-month study, provides a comprehensive road map aimed at …
Amyotrophic lateral sclerosis - Latest research and news - Nature
Jan 10, 2025 · Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty...
Amyotrophic lateral sclerosis (ALS) - MIT News
May 2, 2024 · Deciphering the cellular mechanisms behind ALS Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.
New therapeutic strategy to reduce neuronal death in amyotrophic ...
Nov 16, 2023 · Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now suggested a potential...
New studies point the way to broadly effective treatments for ALS
Feb 7, 2023 · By leveraging a public bioinformatics database to identify how drugs affect the genetic landscape underpinning ALS, the scientists found that suppressing the SYF2 gene would increase the survival...
FDA lifts clinical hold on Amylyx’s Phase I ALS trial
6 days ago · The US Food and Drug Administration (FDA) has lifted a clinical hold on Amylyx Pharmaceuticals’ Phase I trial of AMX0114 in amyotrophic lateral sclerosis (ALS). The lift allows Amylyx to open US sites for screening, enrolment, and dosing in the Phase I LUMINA study (NCT06665165).